$Medicus Pharma (MDCX.US)$
Can This New Skin Cancer Treatment Replace Surgery? Phase 2 Trial Reveals Promising Results

$Medicus Pharma (MDCX.US)$
Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
Thursday, 6th March at 7:30 am
PHILADELPHIA, March 06, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce a positively trending interim analysis for SKNJCT-003 Phase 2 clinical study to non-invasively treat basal cell carcinoma of the skin (B...

$Medicus Pharma (MDCX.US)$
Can This Non-Invasive Therapy Revolutionize Skin Cancer Treatment? Medicus Expands Clinical Trials to UAE

$Medicus Pharma (MDCX.US)$
The interim data analysis timeline and 50% enrollment milestone in Medicus Pharma's Phase 2 SKNJCT-003 trial represents a important inflection point for their novel BCC treatment. The previous Phase 1 results showing 6 complete responses with no serious adverse events provides a strong foundation for Phase 2 success, particularly noteworthy given the diverse patient profile and 100% response rate in nodular BCC cases.
The trial design incorpor...

$Medicus Pharma (MDCX.US)$
Skin Cancer Breakthrough: Medicus Phase 2 Trial Shows Promise After Phase 1 Success

$Medicus Pharma (MDCX.US)$  is this a penny stock?

$Altamira Therapeutics (CYTO.US)$ $ATI Physical Therapy (ATIP.US)$ $Prestige Wealth (PWM.US)$ $Serina Therapeutics (SER.US)$ $Auddia (AUUD.US)$ $Creative Global Technology (CGTL.US)$ $Ambow Education (AMBO.US)$ $Quoin Pharmaceuticals (QNRX.US)$ $Citius Oncology (CTOR.US)$ $Medicus Pharma (MDCX.US)$ $Kindly MD (KDLY.US)$ $Jayud Global Logistics Ltd. (JYD.US)$ $Cheetah Net Supply Chain Service (CTNT.US)$
📊⚡️📊

$Medicus Pharma (MDCX.US)$
Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
Monday, 2nd December at 7:30 am
TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (TSXV: MDCX) ("Medicus" or the "Company") is pleased to announce an agreement with Swanielle Inc. ("Swanielle") to explore expansion of Phase 2 clinical study for treatment of Basal Cell Carcinoma (BCC) in the Asia-pacific region
.
Under the agreemen...

$Reborn Coffee (REBN.US)$ $Medicus Pharma (MDCX.US)$ $Mobix Labs (MOBX.US)$ $X3 Holdings (XTKG.US)$ $Pacific Mercantile Bancorp (PNBK.US)$ $NextPlat (NXPL.US)$ $NextTrip (NTRP.US)$ $Zepp Health (ZEPP.US)$ $Evaxion Biotech (EVAX.US)$ $Onconetix (ONCO.US)$ $Bolt Projects (BSLK.US)$ $Crown Electrokinetics (CRKN.US)$ $Biomerica (BMRA.US)$
📊⚡️📊